Lipoprotein Cofactors Located in the Outer Membrane Activate Bacterial Cell Wall Polymerases  by Paradis-Bleau, Catherine et al.
Lipoprotein Cofactors Located
in the Outer Membrane Activate
Bacterial Cell Wall Polymerases
Catherine Paradis-Bleau,1,4 Monica Markovski,1,4 Tsuyoshi Uehara,1,4 Tania J. Lupoli,3 Suzanne Walker,1,3
Daniel E. Kahne,2,3 and Thomas G. Bernhardt1,*
1Department of Microbiology and Molecular Genetics
2Department of Biological Chemistry and Molecular Pharmacology
Harvard Medical School, Boston, MA 02115, USA
3Department of Chemistry and Chemical Biology, Harvard University, Cambridge, MA 02138, USA
4These authors contributed equally to this work
*Correspondence: thomas_bernhardt@hms.harvard.edu
DOI 10.1016/j.cell.2010.11.037SUMMARY
Most bacteria surround themselves with a peptido-
glycan (PG) exoskeleton synthesized by polysaccha-
ride polymerases called penicillin-binding proteins
(PBPs). Because they are the targets of penicillin
and related antibiotics, the structure and biochem-
ical functions of the PBPs have been extensively
studied. Despite this, we still know surprisingly little
about how these enzymes build the PG layer
in vivo. Here, we identify the Escherichia coli outer-
membrane lipoproteins LpoA and LpoB as essential
PBP cofactors. We show that LpoA and LpoB form
specific trans-envelope complexes with their
cognate PBP and are critical for PBP function
in vivo. We further show that LpoB promotes PG
synthesis by its partner PBP in vitro and that it likely
does so by stimulating glycan chain polymerization.
Overall, our results indicate that PBP accessory
proteins play a central role in PG biogenesis, and
like the PBPs theyworkwith, these factors are attrac-
tive targets for antibiotic development.
INTRODUCTION
To fortify their cytoplasmic membrane and protect it from
osmotic rupture, most bacteria surround themselves with
a peptidoglycan (PG) exoskeleton. This tough polysaccharide
layer is constructed from long glycan chains crosslinked to one
another via attached peptides to form a continuous matrix that
envelops the cell (Figure 1A). Because bacteria are encased
within this polymeric shell, their growth and morphogenesis are
intimately linked to PG synthesis and remodeling; PG expansion
is essential for growth, and the shape of the organism is defined
by the PG network (Margolin, 2009).
The PG synthesis pathway is of tremendous practical impor-
tance because it is the target of many of our most effective anti-1110 Cell 143, 1110–1120, December 23, 2010 ª2010 Elsevier Inc.biotics, notably penicillin and related b-lactams. Since its
discovery over 80 years ago, penicillin has served as a key probe
of the PG assembly process aswell as awidely used therapeutic.
It covalently modifies and inhibits PG synthases called high
molecular weight penicillin-binding proteins (HMW-PBPs)
(Sauvage et al., 2008), which henceforth will be referred to simply
as PBPs. Bacteria typically encode two varieties of PBPs: class
A and class B (Sauvage et al., 2008). Both types are integral
membrane proteins with relatively large domains facing the cell
exterior. Class A PBPs are thought to be the primary cellular
PG synthases because they are bifunctional and have both
peptidoglycan glycosyl transferase (PGT) and transpeptidase
(TP) domains capable of polymerizing the glycan strands of PG
and crosslinking them, respectively (Figures 1A and 1B). Class
B PBPs are mono-functional and only have TP activity.
Although purified bifunctional PBPs can polymerize and
crosslink PG in vitro from lipid-II substrate (Figure 1B) (Bertsche
et al., 2005; Barrett et al., 2007), the PBPs alone are insufficient
for the proper assembly of the cell-shaped PG network in vivo.
To build a dynamic, uniformly shaped PG mesh that grows in
step with the rest of the cell, PBP activity must be spatially and
temporally controlled (Margolin, 2009). Adding to the complexity,
rod-shaped bacteria like Escherichia coli and Bacillus subtilis
must properly switch between different modes of PG growth:
elongation of the cylindrical portion of the rod and synthesis of
the hemispherical polar caps during division. Therefore, it is
not surprising that, besides the PBPs, an array of additional
proteins have been implicated in PG assembly (den Blaauwen
et al., 2008; Margolin, 2009). Recent work indicates that many
of these factors are organized into multienzyme PG-synthesizing
complexes by cytoskeletal polymers of FtsZ (tubulin-like) and
MreB (actin-like), which are thought to direct their activity to
appropriate subcellular locations (Figure 1B). Studies from
a number of laboratories have identified likely components of
these complexes, including: (1) many, if not all, of the enzymes
required for lipid-II synthesis (MurA-MurG); (2) both classes of
synthetic PBPs; (3) various PGhydrolases; and (4) several essen-
tial integral membrane proteins of unknown function, such as
SEDS-domain proteins like RodA or FtsW and the elongation
Figure 1. Cell Wall Structure and Assembly
(A) Schematic of bacterial cells with the cell wall (PG layer) in green. Gram-
negative cells have a relatively thin PG layer surrounded by an additional
(outer) membrane. Above the cells is a schematic detailing the structure of
PG, which continues in all directions to envelop the cell (green arrows). M,
N-acetylmuramic acid; G, N-acetylglucosamine. Dots represent the attached
peptides.
(B) Overview of PG assembly. A generic multiprotein complex (gray) containing
a class A PBP (purple) is shown. For simplicity the other PG assembly factors
thought to participate in the final stages of PG construction are not specifically
labeled. See text for details. PGT, peptidoglycan glycosyltransferase domain;
TP, transpeptidase domain.specific factors MreC and MreD (den Blaauwen et al., 2008;
Margolin, 2009; White et al., 2010). Many questions regarding
the function and composition of these PBP-containing, multien-
zyme complexes remain to be addressed. However, one of the
most fundamental is whether such complexes promote PG
synthesis simply by providing the PBPs with access to substrate
via lipid-II synthesis and flipping (Figure 1B), or whether they also
contain critical accessory factors that facilitate and/or regulate
PBP activity by affecting lipid-II utilization or the incorporation
of nascent PG into the existing network.
Here, we report the discovery of protein cofactors essential for
the in vivo function of the bifunctional PBPs. They were identified
using directed genetic screens in the model Gram-negative
bacterium, E. coli. We have designated them LpoA (YraM) and
LpoB (YcfM) for lipoprotein activators of bifunctional PBP activity
from the outer membrane. We demonstrate that they directly
affect PBP activity through the formation of specific trans-enve-Clope Lpo-PBP complexes. In addition we show that LpoB
promotes PG synthesis by its partner PBP in vitro and that it
does so by stimulating glycan chain polymerization. Overall,
our results indicate that PBP accessory proteins play a central
role in PG biogenesis, and like the PBPs they work with, these
factors are attractive targets for antibiotic development. In this
issue of Cell, an accompanying report from Typas et al. (2010)
describes the independent discovery of the Lpo factors using
large-scale phenotyping and proteomic approaches.
RESULTS
Rationale for the Synthetic Lethal Screens
E. coli, like many bacteria, encodes multiple class A PBPs:
PBP1a, PBP1b, and PBP1c (Sauvage et al., 2008). Prior genetic
studies indicated that cells remain viable if either PBP1a or
PBP1b is inactivated, but not if they both are (Yousif et al.,
1985; Kato et al., 1985). This suggests that there are at least
twomajor PG-synthesizing complexes in the cell, one containing
PBP1a and the other PBP1b, an idea supported by crosslinking
studies in Haemophilus influenzae and immunoprecipitation
studies in E. coli (Charpentier et al., 2002; Alaedini and Day,
1999). Based on this, we reasoned that we could identify critical
components of these multienzyme PBP complexes by perform-
ing a screen for mutations synthetically lethal with the loss of
either PBP1a or PBP1b. For example if factor X is an important
component of a PBP1a synthetic complex, one might expect
mutations that inactivate factor X to be just as lethal when
PBP1b is depleted as the inactivation of PBP1a is. Therefore,
a screen for mutants synthetically lethal with the loss of PBP1b
should yield factor X mutants as well as ponA (PBP1a) mutants.
The converse is also true. Important components of the PBP1b
synthetic complex should be identified by a screen for mutants
synthetically lethal with the loss of PBP1a.
Screening for Mutants Synthetically Lethal
with the Loss of PBP1a or PBP1b
Our synthetic lethal screen employed methodology we used
previously to identify new cell division factors and regulators of
division site placement (Bernhardt and de Boer, 2004, 2005).
To apply the screen to the PBPs, we initially searched for
mutants synthetically lethal with the loss of PBP1b function
(slb mutants). Our parental strain for the screen had chromo-
somal deletions removing both lacZ and ponB (PBP1b). The
strain also harbored an unstable plasmid containing both the
ponB and lacZ genes under control of the inducible lactose
promoter (Plac). Because PBP1b is not essential, cells frequently
lost the plasmid when they were grown on nonselective media
containing the Plac inducer, IPTG, and the LacZ indicator,
X-gal. They formed either white (LacZ-) colonies or blue-sectored
colonies resulting from plasmid loss before or during colony
formation, respectively (Figures 2A and 2B). To find slb mutants
wemutagenized the parental strain with a transposon and plated
the resulting library on indicator medium to look for rare
solid-blue colonies (Figures 2A and 2B). Mutants forming such
colonies presumably could not lose the plasmid because the
transposon insertion rendered PBP1b essential. To confirm
this we tested the slb candidates for growth with or withoutell 143, 1110–1120, December 23, 2010 ª2010 Elsevier Inc. 1111
Figure 2. Synthetic Lethal Screens and Terminal Phenotypes
(A and B) Colonies of transposonmutants used for the slbmutant screen grown on an indicator plate (LB-IPTG-X-gal) for 2 days at 30C. The arrow points to a rare
solid-blue colony that retained the unstable plasmid. The boxed region in (A) is enlarged in (B).
(C) Schematics indicating the approximate locations of the transposon insertions in the lpo genes. Triangles represent transposon insertion points (green, tran-
scription of the KanR cassette is in the same direction as the target gene; red, transcription is in the opposite direction).
(D) Plating defects of representative slb and slamutants isolated in the screens. Cells of TU122/pTU110 [DponB/Plac::ponB lacZ] (top) or TU121/pCB1 [DponA/
Plac::gfp-ponA lacZ] (bottom) and their derivatives with the indicated transposon insertions were grown overnight at 30
C. Culture densities were normalized,
10-fold serial dilutions were prepared for each, and 5 ml of each dilution was spotted onto LB with or without IPTG as indicated.
(E) Cells of TU121(attlTB309) [DponA(Para::ponA)] (top) or MM11 [Para::ponB] (bottom) and their derivatives were grown overnight at 37
C. Serial dilutions were
prepared as in (D), and dilutions were spotted onto the indicated media.
(F and G) Strains used in (E) were grown in LB-arabinose at 37C to an OD600 = 0.6–1.1. They were then pelleted, washed three times with LB, and resuspended in
LB-glucose at an OD600 = 0.08 or 0.02 for TU121(attlTB309) (F) or MM11 derivatives (G), respectively. Cell growth following subculture (t = 0) was then monitored
by regular OD600 measurements.
Also see data in Figures S2 and S3.IPTG. Mutants truly dependent on PBP1b for growth should
require the presence of IPTG to induce ponB expression from
the plasmid.
We screened a total of 30,000 colonies and isolated 16 slb
mutants. Less than half of these (five of 16) were completely
dependent on IPTG for growth. Three of the IPTG-dependent
mutants had transposon insertions that mapped to the gene
for PBP1a (ponA), indicating that the screen worked as expected
(Figure 2D). Two of the remaining IPTG-dependent mutants had
transposons that mapped within lpoA (yraM) (Figures 2C and
2D). The lpoA reading frame codes for a 678 amino acid protein
with an LppC domain that is well conserved among the g-proteo-
bacteria but has an unknown function (Finn et al., 2008; Vijaya-
lakshmi et al., 2008). LpoA is also predicted to have a lipoprotein
signal sequence for targeting it to the outer membrane (see
below). Besides the ponA and lpoA alleles, most of the remaining1112 Cell 143, 1110–1120, December 23, 2010 ª2010 Elsevier Inc.slb isolates showed a synthetically sick phenotype in combina-
tion with a PBP1b defect. They all had transposon insertions
that mapped to genes encoding factors previously implicated
in cell division and will be described as part of a separate report.
We also performed the converse screen for mutants syntheti-
cally lethal with the loss of PBP1a function (sla mutants).
The screen design was identical to the one described above
except that the parental strain was deleted for the ponA
(PBP1a) gene, and gfp-ponA was encoded on the unstable
plasmid. A total of 41 sla mutants displaying IPTG-dependent
growth were isolated. The majority (34/41) were found to have
transposon insertions disrupting the gene coding for PBP1b
(Figure 2D), and seven of 41 sla mutants had transposon inser-
tions disrupting the gene coding for LpoB (YcfM) (Figures 2C
and 2D). LpoB is a 213 amino acid protein of previously unknown
function that, like LpoA, is predicted to have a lipoprotein signal
sequence for targeting it to the outer membrane (see below).
Because the bias in the isolation of ponB mutants might have
prevented us from identifying additional sla loci, we repeated
the sla screen in a strain containing a second copy ofponB. In this
case only onemutantwas isolated, and it contained a transposon
insertion in lpoB. Therefore, we conclude that ponB and lpoB are
likely to be the only sla loci in the genome.
Specificity of the Synthetically Lethal Combinations
and Their Terminal Phenotypes
To test the specificity of the synthetic lethal combinations, we
constructed strains TU121(attlTB309) [DponA(Para::ponA)] and
MM11 [Para::ponB] in which the production of either PBP1a or
PBP1b was controlled by the arabinose promoter, respectively.
In the case of TU121(attlTB309), the native ponA locus was
deleted, and a second copy of ponA under arabinose promoter
control was integrated at the l att site. For MM11 the native
ponB promoter was replaced with the arabinose promoter.
Growth of TU121(attlTB309) [DponA(Para::ponA)] derivatives
lacking PBP1b or LpoB was severely inhibited on media without
arabinose (Figure 2E). Growth of the corresponding LpoA strain
was unaffected (Figure 2E). Similarly, MM11 [Para::ponB] deriva-
tives defective for PBP1a or LpoA failed to grow without arabi-
nose supplementation, whereas the corresponding LpoB strain
showed robust growth (Figure 2E). Thus, LpoA is specifically
required in the absence of PBP1b, and LpoB is specifically
required in the absence of PBP1a.
The terminal phenotype of PBP1a depletion in the absence of
PBP1b is cell lysis, and vice versa (Figures 2F and 2G) (Yousif
et al., 1985). To determine if cells lacking specific Lpo-PBP1
combinations also lyse, we followed the growth and morphology
of strains lacking Lpo factors after initiating PBP1 depletion.
When PBP1a was depleted, cells lacking PBP1b or LpoB
displayed a dramatic lysis phenotype. About three generations
following the initiation of PBP1a depletion, the optical density
of the mutant cultures began to decline rapidly (Figure 2F).
This coincided with the appearance of cell ghosts and lysing
cells with membrane blebs in the cultures (see Figure S1
available online). The only difference between the PBP1b and
LpoB cells upon PBP1a depletion was that the LpoB cells
consistently began lysing about 10 min later than PBP1b cells
(Figure 2F). Similar results were obtained when we compared
the effect of PBP1b depletion on cells defective for PBP1a or
LpoA. In both cases the terminal phenotypewas lysis (Figure 2G).
As on plates, growth of PBP1a LpoA or PBP1b LpoB cells in
liquid was normal (data not shown). Importantly, the synthetic
lethal phenotypes resulting from the lpoA or lpoB deletions
were corrected by their expression in trans, indicating that the
phenotypes observed were not due to an adverse effect of the
deletions on the expression of nearby genes (Figure S2). In addi-
tion, Bocillin labeling and immunoblotting indicated that the
defects observed for the LpoA/B mutants were not due to
a decrease in PBP1 protein levels (Figure S3).
Although PBP1a and PBP1b appear to be largely redundant,
the phenotypes of cells lacking individual PBP1s are not iden-
tical. Loss of PBP1b leads to a hypersensitivity to b-lactam anti-
biotics that is not observed for PBP1a mutants (Schmidt et al.,
1981; Yousif et al., 1985). In addition, inhibition of the class BCPBPs, PBP2 with mecillinam or PBP3 with cephalexin, normally
leads to the formation of spherical or filamentous cells, respec-
tively, that are slow to lyse (Spratt and Pardee, 1975). However,
similar treatments of mutants lacking PBP1b rapidly induce cell
lysis (Schmidt et al., 1981; Garcı´a del Portillo and de Pedro,
1990). Although the reasons for the aberrant b-lactam pheno-
types of PBP1b mutants are not known, we used these observa-
tions to further investigate the equivalence of LpoB and PBP1b
defects. We found that LpoB defective mutants indeed shared
a b-lactam hypersensitivity phenotype with PBP1b mutants
(Figure S4A). Moreover, LpoB cells also lysed rapidly when
treated with mecillinam or cephalexin (Figures S4B–S4D).
Thus, a LpoB mutant has all of the hallmarks of a PBP1b
defect.
At Least One Lpo Factor Is Required for Growth
Our results thus far suggest that LpoA is important for PBP1a
function and that LpoB is important for PBP1b function. If this is
true, then the combined loss of LpoA and LpoB should pheno-
copy the lysis and lethality observed when PBP1a and PBP1b
are simultaneously inactivated. Accordingly, when LpoA was
depleted in the absence of LpoB, cells lysed and failed to grow
onmedia lacking inducer for lpoAexpression (Figures3Aand3B).
The Lpo Factors Are Essential for PBP1 Function
To determine whether or not the Lpo proteins are essential for
PBP1 function, we tested the ability of PBP1a/b overproduction
to suppress the synthetic lethal phenotypes associated with
a LpoA/B defect. Overproduction of PBP1a by approximately
4-fold from plasmid pCB62 [Plac-con::ponA] was not sufficient
to suppress the Slb phenotype of MM13 [Para::ponB DlpoA] cells
upon PBP1b depletion in liquid or solid medium (Figures 3C, 3E,
and 3G). Only a minor delay in the timing of lysis was observed
forMM13 cells harboring pCB62 relative to pTB284 [Plac-con::gfp]
(Figure 3C). Similarly, an approximately 8-fold overproduction of
PBP1b from pCB72 [P
lac-con
::ponB] failed to rescue the lytic
phenotype and plating defects of CB4(attlTB309) [DponA
DlpoB(Para::ponA)] cells depleted of PBP1a (Figures 3D, 3F,
and 3G). We conclude that the Lpo proteins are essential for
the in vivo function of their cognate PBP as opposed to factors
that simply stimulate PBP activity but are not critical for their
function.
Lpo Factors Localize throughout the Outer Membrane
Based on the sequence of their signal peptides, LpoA and LpoB
are both predicted to be outer-membrane lipoproteins (Fig-
ure S5A). To test this we used a cytological assay for lipoprotein
transport developed by Pugsley and coworkers (Lewenza et al.,
2006). In this assay, cells expressing a fluorescent protein fused
to a lipoprotein or lipobox-containing signal sequence are visual-
ized following osmotic shock. This treatment induces the forma-
tion of plasmolysis bays where the inner membrane retracts from
the rest of the cell envelope. Thus, a fluorescently labeled
lipoprotein that is retained in the inner membrane will localize
to the invaginations of the plasmolysis bays, whereas an outer-
membrane lipoprotein will retain a peripheral localization pattern.
Before osmotic shock, GFP fusions to LpoA and LpoB
displayed a patchy, nonuniform peripheral localization patternell 143, 1110–1120, December 23, 2010 ª2010 Elsevier Inc. 1113
Figure 3. Lpo Factors Are Essential for Growth and PBP1 Function
(A) Cells of MM22(attHKMM10) [DlpoA(Plac::lpoA-gfp)] and its derivatives were grown overnight in LB-IPTG (50 mM) at 37
C. Serial dilutions were prepared as in
Figure 2 and spotted onto the indicated solid media. Identical results were obtained when LpoB was depleted in the absence of LpoA (data not shown).
(B) Cultures of cells from (A) were grown to an OD600 of 0.3–0.4 in LB-IPTG (50 mM) at 37
C. The cells were then pelleted, washed three times with LB, and
resuspended in LB-glucose at an OD600 = 0.02. Cell growth following subculture (t = 0) was then monitored by regular OD600 measurements.
(C and D) Cells of MM13 [Para::ponBDlpoA] (C) or CB4(attlTB309) [DponADlpoB(Para::ponA)] (D) containing the low-copy plasmids pTB284 [Plac-con::gfp], pCB62
[Plac-con::ponA], or pCB72 [Plac-con::ponB] were grown to an OD600 of 0.5–0.7 in LB-Ara-Spc (C) or M9-Ara-Spc (D) at 37
C. They were then washed, diluted into
LB-IPTG (1 mM), and growth at 37C was followed as in (B).
(E and F) To determine the extent of PBP1a or PBP1b overproduction in the cultures from (C) and (D), respectively, extracts were prepared from cells harvested at
times indicated by the arrows above the growth curves (C and D). Immunoblot analysis was then performed to determine the levels of PBP1a (E) or PBP1b (F) in
strains MM13/pCB62 or CB4(attlTB309)/pCB72, respectively, relative to corresponding control strains harboring pTB284. Numbers above lanes indicate the
amount of total protein loaded.
(G) Cultures of TB28 [WT], MM13, or CB4(attlTB309) containing the aforementioned plasmids were diluted, plated on the indicated media containing Spc, and
incubated overnight at 37C. Plasmids pCB62 [Plac-con::ponA] and pCB72 [Plac-con::ponB] possess native ribosome binding sites and 50UTRs for ponA and ponB,
respectively. pCB72 likely has a higher basal level of expression than pCB62 because it can correct the PBP1B- LpoA phenotype of MM13 without IPTG induc-
tion. Plac-con is a synthetic lac promoter with consensus 35 and 10 elements.
Also see data in Figures S1 and S4.(Figures S6E and S6G), indicating that they are broadly distrib-
uted throughout the envelope. In unconstricted cells, GFP-
LpoA and GFP-LpoB retained their peripheral distribution
following osmotic shock, suggesting that they are indeed
outer-membrane proteins (Figures 4A and 4D). This was
confirmed using membrane fractionation experiments (Figures
S5B–S5E). In dividing cells theGFP-LpoA andGFP-LpoB signals
became enriched at the septum following osmotic shock
(Figures S6F and S6H). This was also observed for GFP-
PBP1b, but not GFP-PBP1a (Figures S6A–S6D). It is not clear
why plasmolysis leads to the enrichment of these fusion proteins
at the septum, but this may reflect some propensity of the native
proteins to be recruited to the division apparatus (Bertsche et al.,
2006; Typas et al., 2010).1114 Cell 143, 1110–1120, December 23, 2010 ª2010 Elsevier Inc.To determine the importance of outer membrane localization
and/or lipidation for Lpo factor function, we generated LpoA-
GFP and LpoB-GFP variants with D+2 D/E+3 substitutions in their
signal sequences to cause their retention in the inner membrane
(Figure S5A), as well as variants in which the entire lipoprotein
signal sequence was replaced with that of DsbA, a secreted
periplasmic protein. All variants displayed the expected localiza-
tion pattern following osmotic shock (Figures 4A–4F). Fusions
with the DsbA signal sequence appeared to fill the periplasm
of the plasmolysis bays (Figures 4B and 4E), and those with
the D+2 D/E+3 substitutions appeared to colocalize with invagina-
tions of the inner membrane where it retracted from the envelope
(Figures 4C and 4F). We tested the ability of these variants to
support the function of their cognate PBP1 by assaying whether
Figure 4. LpoA and LpoB Are Outer-Membrane Lipoproteins
(A–F) Cytological assay of membrane localization. Cells of MM13 [Para::ponBDlpoA] (A–C) or CB4(attlTB309) [DponADlpoB(Para::ponA)] (D–F) harboring the inte-
grated expression constructs (A) attHKMM10 [Plac::lpoA-gfp], (B) attHKCB42 [Plac::
ssdsbA-lpoA-gfp], (C) attHKMM50 [Plac::lpoA(D
+2D+3)-gfp], (D) attHKCB28
[Plac::lpoB-gfp], (E) attHKCB41 [Plac::
ssdsbA-lpoB-gfp], or (F) attHKMM51 [Plac::lpoB(D
+2E+3)-gfp] were grown at 30C to mid log in M9-arabinose supplemented
with 100 mM IPTG. The cells were then plasmolyzed and visualized using GFP (panel 1) and phase contrast (panels 2) optics. Arrows highlight clear examples of
protein localization (outer membrane, A and D; periplasm, B and E; inner membrane, C and F). Bar equals 2 mm.
(G and H) Functionality of signal sequence mutants.
Cultures of cells from (A)–(F) were diluted and plated on the indicated media as described in Figure 2. Also see data in Figures S5 and S6.or not they could correct the synthetic lethal phenotypes of Lpo/
PBP1 mutant combinations. As shown in Figure 4G, LpoA
variants with a DsbA signal peptide or the D+2 D+3 double substi-
tution were not active, suggesting that LpoA must be targeted to
the outer membrane to promote PBP1a function. Immunoblot
analysis showed that all of the LpoA variants were produced at
levels similar to the wild-type protein (data not shown), indicating
that the observed defects were not due to reduced protein
accumulation. In contrast to the results with LpoA, all of the
LpoB variants were functional (Figure 4H), suggesting that
LpoB does not need to be lipidated or transported to the outer
membrane to support PBP1b function.
Specific Interaction of the Lpo Factors with Their
Cognate PBP
Overall, our results suggest that the Lpo factors are promoting
the in vivo activity of the PBP1s. To test whether they do so
directly, we purified untagged versions of PBP1a and PBP1b,
and 63His tagged versions of LpoA (H-LpoA) and LpoB
(H-LpoB) lacking their signal sequences and lipid modification
signals. We then used a pull-down assay to investigate potential
PBP1-Lpo interactions. When PBP1a (4 mM) was incubated with
H-LpoA (4 mM), it was found in the eluate from Ni-NTA beads
following two wash steps (Figure 5A). Purified FtsZ (4 mM) was
included in the binding reactions as a negative control. It was
not retained on the beads, indicating that the washes were effec-
tive. In contrast to the results with PBP1a, only a very smallCamount of PBP1b co-purified with H-LpoA (Figure 5B).
Conversely, when PBP1a (4 mM) or PBP1b (4 mM) was incubated
with H-LpoB (4 mM), PBP1b was specifically retained on NiNTA
beads (Figures 5C and 5D). Thus, as implied by the genetic
results, LpoA specifically associates with PBP1a, whereas
LpoB specifically associates with PBP1b.
Similar amounts of Lpo and PBP1 proteins appeared to elute
from the Ni-NTA resin, suggesting that the PBP1-Lpo stoichiom-
etries in the isolated complexes were close to 1:1. Accordingly,
the cellular copy numbers of the Lpo factors measured using
semiquantitative immunoblotting mirrored those determined for
their cognate PBPs. About 500 molecules per cell each of
LpoA and PBP1a were detected, whereas PBP1b and LpoB
were found to have copy numbers of about 1000 and 2300
molecules per cell, respectively. Therefore, the in vivo PBP1:Lpo
stoichiometry is in the range of 1:1 to 1:2. The measured
PBP1a/b levels were two to four times higher than those deter-
mined previously using radiolabeled penicillin as a probe
(Dougherty et al., 1996) but were consistent with past measure-
ments of PBP1b levels by immunoblotting (den Blaauwen and
Nanninga, 1990). Thus, radiolabeled penicillin appears to under-
estimate PBP levels when used for copy number determinations.
Lpo Factors Promote PBP Activity In Vivo and In Vitro
To assess the effect of the Lpo proteins on PG assembly, we
compared the chemical composition of wild-type PG with PG
isolated from PBP1a PBP1b or LpoA LpoB cells just beforeell 143, 1110–1120, December 23, 2010 ª2010 Elsevier Inc. 1115
Figure 5. LpoA and LpoB Specifically Interact with Their Cognate
PBP
(A–D) H-LpoA (A and B) or H-LpoB (C and D) was incubated with PBP1a (A and
C) or PBP1b (B and D) for 60min at room temperature in binding buffer (20 mM
Tris [pH 7.4], 0.1% Triton X-100, and either 300 or 150 mMNaCl for A and B or
C and D, respectively). Ni-NTA resin (QIAGEN) was then added to each
reaction, and they were further incubated for 2 hr at 4Cwith rotation. The resin
was pelleted by centrifugation, washed twice with binding buffer containing
20 mM imidazole, and the proteins retained on the resin were eluted with
sample buffer containing EDTA (100mM). Proteins in the initial reaction (input),
initial supernatant (UB), wash supernatants (W1 and W2), and eluate were
separated on a 12% SDS polyacrylamide gel and stained with Coomassie
brilliant blue. FtsZ was included in each reaction as a nonspecific control.
All proteins were present in the initial binding reaction at a concentration of
4 mM. Positions of molecular weight markers (numbers in kDa) are given to
the left of each gel.they lysed (Table S1). For the analysis, purified PG was digested
with a muramidase (mutanolysin) that cleaves the b-1,4 linkages
between the N-acetylmuramic acid (M) and N-acetylglucos-
amine (G) sugars of PG (Figure 1A). The resulting mixtures of
muropeptides, primarily consisting of monomeric G-M disac-
charides with attached peptides or dimeric G-M disaccharides
connected by crosslinked peptides, were separated by HPLC
and the component muropeptides quantitated. The absence of
either the PBP1s or the Lpo proteins caused a strikingly similar1116 Cell 143, 1110–1120, December 23, 2010 ª2010 Elsevier Inc.alteration in relative PG composition. PG from the mutants
showed a decrease in peptide crosslinking, from 22% in the
wild-type control down to 18%–19% (Table S1). In addition
a dramatic increase (4- to 7-fold) in pentapeptide-containing
muropeptides was observed in the PG isolated from the mutants
(Table S1). Because the terminal D-Ala is cleaved from penta-
peptides as part the PBP-crosslinking reaction, the observed
increase in pentapeptides in the mutant PG preparations
coupled with the reduction in crosslinking is consistent with
a failure in the efficient incorporation of new PG material into
the existing cell wall network.
Next, we examined the effect of LpoB on PG synthesis in vitro
using ether-permeabilized (EP) cells. In the latter stages of the
PG synthesis pathway, lipid-II (Figure 1B) is made from the
activated sugar precursors UDP-M-pentapeptide (UDP-M-
pep5) and UDP-G. PG synthesis can be reconstituted and
measured in EP cells by supplying them with purified UDP-M-
pep5 and UDP-[
14C]G and monitoring the incorporation of label
into the detergent-insoluble PG fraction (Mirelman et al., 1976).
PBP1b appears to be the major PBP responsible for PG
synthesis in this system because EP cells from PBP1bmutants
are almost completely defective in label incorporation, whereas
the absence of PBP1a has little to no effect (Figure 6A) (Tamaki
et al., 1977). Thus, EP cells provide a convenient system for
following PBP1b activity in a cellular context. To determine if
LpoB is required for PBP1b activity in this system, we prepared
EP cells from a LpoB mutant and tested their ability to synthe-
size PG. LpoB EP cells behaved identically to those prepared
from a PBP1b mutant and were dramatically reduced in their
ability to incorporate UDP-[14C]G into the detergent-insoluble
PG fraction (Figure 6A). Remarkably, the addition of purified
untagged LpoB completely restored the ability of LpoB EP cells
to synthesize PG (Figure 6A), indicating that the PG synthesis
defect was due solely to the absence of LpoB. As expected
based on prior results with PBP1a mutants, a LpoA defect
did not affect PG synthesis in EP cells (Figure 6A).
To further investigate LpoB function, we monitored its effect
on the PGT activity of PBP1b in a purified system using radiola-
beled lipid-II substrate. LpoB specifically enhanced the initial
rate of PBP1b transglycosylation by an average of 1.53
(Figure 6B). However, it did not affect the activity of PBP1a,
nor did LpoA affect the PGT activity of either PBP (Figures 6B
and 6C). Although the effect of LpoB on the rate of PBP1b
PGT activity was relatively modest, it specifically affected the
length of glycan chains produced by PBP1b. Much shorter
polymers were produced in the presence of LpoB than those
formed in its absence (Figure 6D). We propose that this indicates
that LpoB stimulates the initiation of glycan strand formation (see
Discussion). Overall, we conclude that LpoB is absolutely
required for PBP1b function in a cellular context and is capable
of directly and specifically modulating PBP1b PGT activity in
a purified system.
DISCUSSION
Despite the fundamental role of PG assembly in bacterial growth
and its long history as an effective antibiotic target, we are only
just beginning to uncover the molecular mechanisms underlying
Figure 6. LpoB Activates PBP1b PGT Activity and Affects Polymer
Length
(A) PG synthesis in EP cells. EP cells from the indicated strains were incubated
with or without LpoB (0.5–4 mM, as indicated). Reactions were initiated with the
addition of UDP-M-pentapeptide (4 nmol) and UDP-[14C]G. After 60 min they
were boiled in 4% SDS and filtered. Labeled PG retained on the filter was
quantified by liquid scintillation counting.
Cthis complex process. Over the years, a great deal of effort has
focused on the structural and biochemical characterization of
the PBPs, the major PG synthases. This has led to important
insights into the mechanisms by which these enzymes catalyze
PG polymerization and crosslinking, how they are inhibited by
antibiotic molecules, and why certain variants confer antibiotic
resistance (Sauvage et al., 2008). Although much still remains
to be learned about the biochemical function of the PBPs,
progress in this area has significantly outpaced our knowledge
of the in vivo function of the PBPs and how they cooperate
with other cellular factors to build the cell-shaped PG mesh.
One of the principal reasons for this is that functional redundancy
among PG assembly factors has limited the effectiveness of
genetic analysis. Here, we turned this redundancy into an advan-
tage by employing synthetic lethal screens to uncover the E. coli
lipoproteins LpoA and LpoB as the first set of essential PBP
cofactors (Figure 7). Our results suggest that, like other polymer-
ases, the PBPs may generally require accessory factors to
augment or regulate their activity. Moving forward, these factors
will surely play a significant role in advancing both our under-
standing of PBP function in vivo and PBP enzymology in vitro.The Outer Membrane and PG Biogenesis
Although PG precursor biosynthesis occurs inside the cell, the
final stages of PG assembly take place at the cell surface (Fig-
ure 1B). This presents an interesting challenge for bacteria,
whichmust somehow coordinate PG assembly outside the cyto-
plasmic membrane with processes that control growth and
division on the inside. Recent results indicate that this coordina-
tion is, at least in part, mediated by the MreB and FtsZ cytoskel-
etons (Margolin, 2009).
Because they surround their PG layer with a second (outer)
membrane, Gram-negative bacteria face the additional chal-
lenge of coordinating PG synthesis with outer membrane
assembly. The discovery of LpoA and LpoB as outer-membrane
activators of the PBPs suggests that they may play an important
role in coupling outer membrane biogenesis and PG synthesis.
Although further work is required to test this possibility, it high-
lights the potential for the PG synthetic machinery receiving
regulatory input from the outer membrane as well as cytoskeletal
elements in the cytoplasm. An equally attractive possibility is that
the outer membrane localization of the Lpo factors might facili-
tate a ‘‘template’’ function for the existing PG matrix. The glycan
strands of PG are thought to be oriented perpendicular to the
long axis of the cell (Gan et al., 2008) (Figure S7). Therefore,(B and C) PBP PGT activity was measured by the incorporation of lipid-II into
PG in the presence of penicillin G. [14C]G-labeled lipid-II (4–8 mM) was
incubated with or without LpoA or LpoB (50 nM) prior to the addition of
PBP1a or PBP1b (50 nM), which initiated the reaction. At the indicated time
points, reactions were quenched and analyzed for remaining substrate and
PG product by paper chromatography. Results of single experiments are
shown. They are representative of multiple trials (see Extended Experimental
Procedures).
(D) Glycan chains generated in reactions similar to those in (B) and (C) were
separated on an acrylamide gel (9%) and visualized using a phosphorimager.
Lipid-II substrate was present at 4 mM in each reaction, and protein amounts
are indicated above the gel lanes.
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Figure 7. Model for Lpo Protein Function
Shown are schematic diagrams of putative PBP-containing complexes in
E. coli drawn as in Figure 1. The partial redundancy of PBP1a (lavender) and
PBP1b (brown) suggest that they form part of independent PG synthesizing
(sub)complexes that can substitute for one another. LpoA is an essential
component of the PBP1a complex (left) that potentially stimulates the TP
activity of this PBP (see text for details). LpoB is an essential component of
the PBP1b complex and activates its PGT activity. Please also see model in
Figure S7.adjacent ‘‘tracks’’ of glycan strands are likely to restrict the
lateral diffusion of trans-envelope complexes formed between
the Lpo proteins in the outermembrane and the PBPs in the inner
membrane. We envision that this arrangement would force the
insertion of new PG material along a consistent path directed
by the ‘‘tracks’’ in the existing structure (Figure S7). Thus, as
implied by earlier work (Schwarz and Leutgeb, 1971; Goodell
and Schwarz, 1975), the PG layer itself may collaborate with
cytoskeletal elements to provide a robust mechanism for shape
maintenance and the regular expansion of the PG network.
Importantly, the Lpo factors may represent just one set of poten-
tial connections between the PBPs and the outer membrane.
Indeed, it was shown previously that PBP1b is connected to
the outer membrane through its interactions with the bridging
protein MipA that, in turn, associates with the outer membrane
PG hydrolase MltA (Vollmer et al., 1999). In contrast to LpoB,
neither MipA nor MltA is required for PBP1b activity. However,
the ability of these and potentially other proteins to connect
PBP1b to the outer membrane may be one reason why an outer
membrane localization is not absolutely required for LpoB to
support PBP1b function.Biochemical Activities of LpoA and LpoB
In addition to promoting PBP1b activity in EP cells and stimu-
lating PBP1b PGT activity in vitro, LpoB also caused PBP1b to
produce dramatically shorter glycan chains. A wide range of
glycan strand lengths has been detected in purified cellular
PG, but essentially nothing is known about how strand length
is determined in vivo and whether or not it is regulated. The
observation that LpoB affects the length distribution of glycan
chains produced by PBP1b suggests the attractive possibility1118 Cell 143, 1110–1120, December 23, 2010 ª2010 Elsevier Inc.that it regulates PBP1b product length by stimulating the termi-
nation of glycan synthesis. However, such a role is difficult to
reconcile with the observation that LpoB is essential for PG
synthesis by PBP1b in EP cells. Therefore, we favor a model in
which LpoB stimulates the initiation of glycan chain synthesis
to explain its effect on product length distribution in PBP1b
PGT assays. This model is based on the previous observation
that the length distribution of polymers produced by a variety
of purified PBPs was unaffected by the PBP:substrate ratio
(Wang et al., 2008). Surprisingly, even in reactions with a 1:1
PBP:substrate ratio, where at most only a few turnovers would
be expected, long glycan strands with a size distribution typical
of the PBP being assayed were produced. This suggests that the
initiation step of glycan chain synthesis is rate limiting and that
the subsequent elongation process is rapid and processive
(Wang et al., 2008). Thus, consistent with our observations,
activation of glycan strand initiation by LpoB would be predicted
to result in a greater number of elongating PBP1b polymerases in
PGT reactions such that lipid-II is exhausted before longer
polymer lengths can be achieved. Because LpoB is not abso-
lutely required for PBP1b activity in a purified system, a subset
of PBP1b molecules in PGT reactions lacking LpoB must be
capable of initiating glycan strand formation. However, initiation
may be tightly controlled in the context of multiprotein
complexes formed in vivo leading to a strict LpoB dependence
for PBP1b PGT activity in the cell. Further work will be required
to investigate the potential role of LpoB in glycan chain initiation
and whether, in such a capacity, it serves as a critical PBP1b
regulator that helps coordinate its PGT activity with the activity
of other components of the PG or outer membrane assembly
machinery.
Although our results clearly show that LpoA is essential for
PBP1a function in vivo, we have yet to detect a biochemical
activity that sheds light on the specific role of LpoA in the reac-
tions catalyzed by PBP1a. One potential reason for this is that
lipidation and outer membrane localization of LpoA was shown
to be essential for its activity in vivo, and the protein we purified
was not lipidated. Interestingly, the structure of the C-terminal
domain ofH. influenzae LpoAwas recently solved andwas found
to share similarities with periplasmic solute-binding proteins like
maltose-binding protein (Vijayalakshmi et al., 2008). The closest
structural relative to LpoA is E. coli LivJ (PBD ID# 1z15),
a branched-chain amino acid-binding protein (Vijayalakshmi
et al., 2008). This suggests that LpoA may associate with the
peptide moieties of PG to facilitate crosslinking of nascent mate-
rial into the PGmatrix by PBP1a. Consistent with this idea, in the
accompanying report from Typas et al. (2010), the authors
present evidence that LpoA greatly enhances the formation of
crosslinked PG by purified PBP1a.
A Specific Role for PBP1b-LpoB Complexes in Cell
Division?
At least two distinct multienzyme complexes are thought to be
necessary for proper PG biogenesis in rod-shaped cells: one
organized by MreB for cell elongation and the other organized
by the division protein FtsZ (den Blaauwen et al., 2008). Although
they are individually dispensable for growth, at least one type of
PBP1 protein is thought to be required for the activity of each of
these complexes. Therefore, it seems likely that PBP1a and
PBP1b, along with their associated Lpo activators, are both
capable of productively interfacing with the MreB- and FtsZ-
directed PG synthesizing machineries. Consistent with this
possibility, in normal, unplasmolyzed cells, GFP fusions to the
PBP1s and the Lpo factors were found to localize in patches
and foci that were broadly distributed around the cell periphery
(Figure 4 and Figure S6). In addition, immunofluorescence local-
ization of PBP1b performed previously also found it to be present
in many foci throughout the cell cylinder, although a modest
enrichment at the division sites of constricting cells was also
reported (Bertsche et al., 2006).
Although PBP1a and PBP1b appear to be largely interchange-
able in their capacities to support growth, it is likely that they
display some level of functional specialization in wild-type cells.
Accordingly, PBP1b has been shown to interact with the
division-specific, class B PBP, PBP3, and the division factor
FtsN (Bertsche et al., 2006; Mu¨ller et al., 2007). This suggests
that PBP1b, along with LpoB, may play a specific role in the
division process that PBP1a-LpoA subcomplexes are unable
to perform. Interestingly, a number of mutants with lesions in
genes coding for factors involved in septal PG biogenesis were
isolated using our screen for cells with a Slb phenotype. Rather
than identifying additional cofactors needed for PBP1a activity
like LpoA, we favor the interpretation that these division mutants
have a Slb phenotype because PBP1b cells are partially defec-
tive for cell division and are thus sensitized to further insults to
the division machinery. A similar class of division mutants was
not recovered in the corresponding screen for sla mutants, nor
did the alleles identified in the Slb screen display synthetic
phenotypes with the absence of PBP1a when this was tested
directly (data not shown). The phenotype of the PBP1b/division
mutant combinations in each case was a high frequency of cell
lysis, suggesting that the absence of PBP1b combined with
a defect in one of these division factors often results in
catastrophic failures in septal PG assembly. Further analysis of
these mutants and their connection to PBP1b function should
allow us to elucidate how PBP1b participates in the construction
of the polar PG caps and whether or not this role is unique to
PBP1b-LpoB containing complexes.
Lpo Factor Conservation and the Prospect for Additional
PBP Accessory Proteins
LpoA is broadly conserved among the g-proteobacteria,
whereas LpoB is primarily restricted to the Enterobacteriaceae
family within this class (Finn et al., 2008). Therefore, we suspect
that organisms belonging to bacterial classes other than the
g-proteobacteria are likely to possess PBP accessory proteins
distinct from LpoA and LpoB that also promote the function of
their PBPs. Some of these factors may play critical roles in the
PG assembly process itself, whereas othersmay help coordinate
PG synthesis with additional envelope components like the outer
membranes of other proteobacteria or the teichoic acids of
Gram-positive organisms.
We anticipate that several of the many PBP-interacting
proteins identified previously will also prove to be PBP acces-
sory proteins that directly assist the PBPs in PG assembly. Prime
candidates are the PG hydrolases. These enzymes break bondsCin the PG meshwork and have long been thought necessary for
providing space in the existing matrix for the insertion of new
material. Although this possibility remains attractive on a theoret-
ical basis, experimental support for it is still lacking. Addressing
the role of these and other PBP-interacting factors in PBP
function represents an important challenge for future work.
PBP Accessory Factors and Antibiotic Development
The discovery of penicillin and its ability to inhibit the PBPs to
induce bacteriolysis ushered in the antibiotic age of clinical
medicine. Since then, the PBPs have proven to be one of the
most important drug targets ever identified. Sadly, antibiotic
resistance continues to erode the effectiveness of our current
cache of antibacterial therapies, including penicillin derivatives
and other b-lactams (Taubes, 2008). Regardless of their precise
biochemical function, the discovery of accessory factors essen-
tial for the in vivo function of the PBPs suggests new avenues for
antibiotic development to help combat drug-resistant bacteria.
The observation that LpoA is essential in H. influenzae (Wong
and Akerley, 2003) suggests that direct targeting of PBP acces-
sory proteins might be effective in some circumstances.
Additionally, further study of the mechanisms by which these
accessory factors influence PBP activity is likely to reveal novel
ways to block PBP function for therapeutic purposes.
EXPERIMENTAL PROCEDURES
Media, Bacterial Strains, and Plasmids
Cells were grown in LB (1% tryptone, 0.5% yeast extract, 0.5% NaCl) or
minimal M9 medium supplemented with 0.2% Casamino acids and 0.2%
sugar (arabinose; Ara, glucose; Glu, or maltose; Malt). The bacterial strains
and plasmids used in this study are listed in Tables S2 and S3, respectively,
and a detailed description of their construction is given in Extended
Experimental Procedures.
Synthetic Lethal Screens
Screens for mutants with a Sla or Slb phenotype were performed as described
previously (Bernhardt and de Boer, 2004). Detailed methods are presented in
Extended Experimental Procedures.
Fluorescence Microscopy and Cytological Assay for Membrane
Localization
Fluorescence microscopy was performed essentially as described previously
(Uehara et al., 2009). The cytological assay for membrane localization of
lipoproteins was performed as described previously (Lewenza et al., 2006).
Please see Extended Experimental Procedures for details about growth condi-
tions and sample preparation methods used for specific experiments.
Protein Purification and Biochemical Assays
Detailed protein purification procedures are presented in Extended Experi-
mental Procedures, as are methods used for PG chemical analysis and
biochemical reactions.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Extended Experimental Procedures, seven
figures, and four tables and can be foundwith this article online at doi:10.1016/
j.cell.2010.11.037.
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